These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19739074)

  • 1. Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis.
    Pasquet M; Golzio M; Mery E; Rafii A; Benabbou N; Mirshahi P; Hennebelle I; Bourin P; Allal B; Teissie J; Mirshahi M; Couderc B
    Int J Cancer; 2010 May; 126(9):2090-101. PubMed ID: 19739074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages.
    Castells M; Thibault B; Mery E; Golzio M; Pasquet M; Hennebelle I; Bourin P; Mirshahi M; Delord JP; Querleu D; Couderc B
    Cancer Lett; 2012 Dec; 326(1):59-68. PubMed ID: 22824244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses.
    Martinet L; Poupot R; Mirshahi P; Rafii A; Fournié JJ; Mirshahi M; Poupot M
    Int J Cancer; 2010 May; 126(9):2143-52. PubMed ID: 19739080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
    Kryczek I; Lange A; Mottram P; Alvarez X; Cheng P; Hogan M; Moons L; Wei S; Zou L; Machelon V; Emilie D; Terrassa M; Lackner A; Curiel TJ; Carmeliet P; Zou W
    Cancer Res; 2005 Jan; 65(2):465-72. PubMed ID: 15695388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
    Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
    Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations.
    Katz E; Skorecki K; Tzukerman M
    Clin Cancer Res; 2009 Jan; 15(1):70-80. PubMed ID: 19118034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.
    Byrne AT; Ross L; Holash J; Nakanishi M; Hu L; Hofmann JI; Yancopoulos GD; Jaffe RB
    Clin Cancer Res; 2003 Nov; 9(15):5721-8. PubMed ID: 14654557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
    Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
    Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic trogocytosis with Hospicells induces the expression of N-cadherin by breast cancer cells.
    Lis R; Capdet J; Mirshahi P; Lacroix-Triki M; Dagonnet F; Klein C; Mirshahi M; Fournié JJ; Rafii A; Poupot M
    Int J Oncol; 2010 Dec; 37(6):1453-61. PubMed ID: 21042713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
    Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
    Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
    Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma.
    Ho CM; Chang SF; Hsiao CC; Chien TY; Shih DT
    J Biomed Sci; 2012 Feb; 19(1):23. PubMed ID: 22330345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line.
    Benabbou N; Mirshahi P; Cadillon M; Soria J; Therwath A; Mirshahi M
    Int J Oncol; 2013 Sep; 43(3):685-94. PubMed ID: 23857432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1/Flt-1 using adeno-associated virus serotype 1-derived vector.
    Takei Y; Mizukami H; Saga Y; Yoshimura I; Hasumi Y; Takayama T; Kohno T; Matsushita T; Okada T; Kume A; Suzuki M; Ozawa K
    Int J Cancer; 2007 Jan; 120(2):278-84. PubMed ID: 17066424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer.
    Curiel TJ; Cheng P; Mottram P; Alvarez X; Moons L; Evdemon-Hogan M; Wei S; Zou L; Kryczek I; Hoyle G; Lackner A; Carmeliet P; Zou W
    Cancer Res; 2004 Aug; 64(16):5535-8. PubMed ID: 15313886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.